This is ultimately a referendum on whether you believe in the 3 man advisory panel.
They would have told the board what their plans were, they would have known there would be short term pain, but with a eye for a stronger long term company.
The question is are you backing them to deliver?
They have a minimum of 10 million shares each to collect, (up to 20 million with incentives if they deliver) so significant skin in the game.
We know they are not novices, so with all due respect to everyone else who is commenting, no one has their experience or contact book.
I know they are also getting paid monthly, but that is small fry compared to what they will get if they succeed with a US listing at say $3, $4, or $5.
I'm not having a go at anyone who has sold, or is intending to sell, as we all have different circumstances. But for those with a longer term view the end game still looks good.
Like most here I'm sure, keen to see a revised feasibility study and timetable.
- Forums
- ASX - By Stock
- ABR
- Ann: ABR Defers Phase 1A of Fort Cady Mine to enhance US Listing
Ann: ABR Defers Phase 1A of Fort Cady Mine to enhance US Listing, page-125
-
-
- There are more pages in this discussion • 80 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ABR (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online